Skip to main content
PMC home page
Bulletin of the New York Academy of Medicine logoLink to Bulletin of the New York Academy of Medicine
. 1980 Jan-Feb;56(1):115–138.

The politics of health cost containment: end-stage renal disease.

R A Rettig
PMCID: PMC1808299  PMID: 6986928

Full text

PDF

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Rettig Richard A. The policy debate on patient care financing for victims of end-stage renal disease. Law Contemp Probl. 1976 Autumn;40(4):196–230. [PubMed] [Google Scholar]
  2. Stange P. V., Sumner A. T. Predicting treatment costs and life expectancy for end-stage renal disease. N Engl J Med. 1978 Feb 16;298(7):372–378. doi: 10.1056/NEJM197802162980705. [DOI] [PubMed] [Google Scholar]
  3. Stange P. V., Sumner A. T. Predicting treatment costs and life expectancy for end-stage renal disease. N Engl J Med. 1978 Feb 16;298(7):372–378. doi: 10.1056/NEJM197802162980705. [DOI] [PubMed] [Google Scholar]
  4. Tilney N. L., Strom T. B., Vineyard G. C., Merrill J. P. Factors contributing to the declining mortality rate in renal transplantation. N Engl J Med. 1978 Dec 14;299(24):1321–1325. doi: 10.1056/NEJM197812142992401. [DOI] [PubMed] [Google Scholar]

Articles from Bulletin of the New York Academy of Medicine are provided here courtesy of New York Academy of Medicine

RESOURCES